Posted on: 22 April, 2020
A world-first study by a team from the Kolling Institute may inform the future use of multiple medications by older people, minimising adverse impacts including frailty.
The longitudinal research is the first preclinical study to demonstrate that multiple medications can impair function in old age, and that stopping some can reduce harm.
Research lead, Professor Sarah Hilmer said until now there’s.....
Read more
Category: Research Excellence
Posted on: 15 April, 2020
2020 is an important year for the Kolling Institute as it marks the 100 year anniversary of the research organisation.
As the longest-running medical research institute in New South Wales, the Kolling has a very rich history. Originally named the Institute of Pathological Research of NSW, the organisation was established in a cottage within the grounds of Royal North Shore Hospital in 1920.
Bioche.....
Read more
Category: Research Excellence
Posted on: 07 April, 2020
For nearly three decades, the Kolling Institute Tumour Bank has been quietly and consistently building a large state resource.
It was established in 1992 with a small number of endocrine tumours. Today, it also has breast, colorectal and gynaecological tumour collections, as well as neurological and gastrointestinal samples.
The significance of the resource has been recognised in recent years, and.....
Read more
Category: Research Excellence
Posted on: 06 April, 2020
Professor Mark Molloy’s ground-breaking bowel cancer research has received a boost, with the Cancer Council NSW awarding the Kolling Institute researcher a three-year $450,000 grant.
Professor Molloy has welcomed the funding, saying bowel cancer claims more lives each year than breast, prostate or skin cancer.
“It is now Australia’s second biggest cancer killer, with more than 300 Australians diagn.....
Read more
Category: Funding support
Posted on: 02 March, 2020
In an exciting breakthrough, researchers from the Kolling Institute’s Bill Walsh Lab have identified new genes involved in the spread of ovarian cancer.
Tragically, it is the deadliest female cancer, claiming more than 900 lives in Australia each year. Most women are diagnosed relatively late, when the cancer has spread, significantly reducing their chances of survival.
The ovarian cancer research .....
Read more
Category: Research Excellence
Posted on: 24 February, 2020
New research is testing a new way to meet the rapidly growing demand for physiotherapy in our public hospitals.
A clinical trial at four hospitals, including Hornsby and Royal North Shore, is studying whether some patients can successfully undertake physiotherapy exercises at home and still experience the same benefit provided by attending a hospital clinic.
“Demand for physio is increasing rapidl.....
Read more
Category: New Treatment
Posted on: 14 February, 2020
RNSH cardiologist Professor Geoffrey Tofler has led a world-first study which found that common medications can reduce the risk of heart attack in those grieving a loved one.
Professor Tofler said while most people gradually adjust to the loss of a loved one, there is an increase in heart attacks and death among bereaved people, particularly those grieving a spouse or child.
“This risk can last up.....
Read more
Category: Research Excellence
Posted on: 22 January, 2020
Celebrity couple Hayden James and Jennifer Luby shared their emotional journey following the premature birth of their son during the inaugural Women and Babies Research team seminar at the Kolling.
Hayden, an award winning Australian musician and DJ, and his wife Jennifer, a Sydney-based artist, spent 87 days in the Neonatal Intensive Care Unit at RNSH last year. Their son James was born at 30 wee.....
Read more
Category: Research Excellence